4M Therapeutics
Pre-clinicalWe develop targeted therapies for the treatment of neuropsychiatric and neurodegenerative conditions by modulating key pathways associated with neuronal health.
Founded
2020
Focus
Small Molecules
About
We develop targeted therapies for the treatment of neuropsychiatric and neurodegenerative conditions by modulating key pathways associated with neuronal health.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile